Search clinical trials for: ER OROS paliperidone

Total 1043 results

Adamas Pharmaceuticals, Inc.

Terminated

Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID. (ALLAY-LID-I)

Parkinson's Disease | Levodopa Induced Dyskinesias (LID)

France, Spain, Germany, Canada, United States
Rigshospitalet, Denmark
The Novo Nordic Foundation

Recruiting

Pre-habilitation Interventions to Empower Patients With Chronic Pain

Chronic Non-Cancer Pain

Denmark
Val Lowe

Enrolling by invitation

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia

Alzheimer Disease

United States
alaa

Completed

Erbium Chromium: YSGG Laser Effect on Surgical Treatment of Chronic Periodontitis

Generalized Chronic Periodontitis
Trevi Therapeutics

Completed

Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Pruritus | Uremic Pruritus

United States, Poland, Romania
Children's Hospital Medical Center, Cincinnati
National Institute of Mental Health (NIMH)

Completed

Attention Deficit Disorder Medication Response Study

ADHD - Combined Type | ADHD - Inattentive Type

United States
Alza Corporation, DE, USA

Completed

An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg

Analgesia
Vanderbilt University Medical Center
Aerocrine AB

Withdrawn

Smartphone-facilitated Asthma Control (SNAPP)

Childhood Asthma

United States
Ann & Robert H Lurie Children's Hospital of Chicago

Completed

Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study

Sickle Cell Disease | Sickle B+ Thalassemia | Sickle Beta Zero Thalassemia | Sickle Cell Hemoglobin C

United States
Acorda Therapeutics

Completed

A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke

Ischemic Stroke

United States
Alexandra Hospital, Athens, Greece
University of Athens

Unknown

Administration of Arginine Supplementation in Preterm Infants

Necrotizing Enterocolitis

Greece
Acorda Therapeutics

Completed

A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets. (MILESTONE℠)

Post-Ischemic Stroke

United States, Canada
Eye Pharma
Bascom Palmer Eye Institute

Completed

Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis

Uveitis

United States
Massachusetts General Hospital
The American Professional Society of ADHD and Related Disorders (APSARD)

Completed

Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study

Attention Deficit Hyperactivity Disorder (ADHD) | Executive Function Deficits (EFD)

United States
Uskudar University

Completed

Effects of Exercise on Sleep Quality in Patients With Obstructive Sleep Apnea Syndrome

Osa Syndrome

Turkey
Janssen Scientific Affairs, LLC

Available

Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma

Multiple Myeloma
Mansoura University Children Hospital

Completed

Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility (OPAMM)

Preterm Infant | Feeding Disorder Neonatal | Gastrointestinal Motility Disorder

Egypt
Organon and Co

Completed

To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)

Hypercholesterolemia
Florida International University

Completed

Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth

Growth | ADHD

United States
Janssen-Cilag International NV

Completed

An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia (PERTAIN)

Schizophrenia

Poland, Israel, Romania, Germany, Lithuania, Croatia, France
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose

Schizophrenia
Mead Johnson Nutrition

Completed

Clinical Effectiveness and Safety of a Novel Oral Rehydration Solution

Gastroenteritis Acute

Thailand
UMC Utrecht

Completed

European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)

Schizophrenia

Netherlands, Norway, Austria, Belgium, Bulgaria, Czechia, Denmark, Germany, Greece, Hungary, Israel, Italy, Poland, Romania, Spain, United Kingdom
Acorda Therapeutics

Terminated

Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine. (MILESTONE℠)

Post-ischemic Stroke

United States, Canada
Acorda Therapeutics

Completed

Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis

Multiple Sclerosis

United States
Trevi Therapeutics

Completed

Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis

Pruritus | Prurigo Nodularis | Prurigo | Nodularis Prurigo

United States, Germany, Poland
Zogenix, Inc.

Completed

A Study to Determine the Influence of Co-ingestion of Alcohol on Hydrocodone Bitartrate Extended Release (HC-ER)

Healthy
Deborah Doroshow

Recruiting

Leflunomide in Patients With PTEN-null Advanced Solid Malignancies

PTEN-null Advanced Solid Tumors

United States
Impax Laboratories, LLC

Completed

IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

Multiple Sclerosis

United States, Canada, Estonia, Latvia, Ukraine
Yuzuncu Yıl University

Completed

Comparison of Er,Cr:YSGG and Diode Lasers In Second Stage Implant Surgery

Postoperative Pain | Wound Heal | Soft Tissue Bleeding

Turkey
Ottawa Hospital Research Institute
Advanced Bionics

Unknown

Recipients With Limited Bimodal Benefit: HA or CROS

Hearing Disability | Cochlear Implant | Hearing Disorders and Deafness

Canada
Bausch Health Americas, Inc.

Completed

Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease

Sickle Cell Disease

United States, Canada, Kenya
AstraZeneca

Completed

To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy Volunteers

Parkinson's Disease

United Kingdom
Pharmathen S.A.

Completed

A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment

Schizophrenia

Jordan
Janssen-Cilag Pty Ltd

Completed

Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)

Schizophrenia

Australia
Johnson & Johnson Pte Ltd

Completed

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia

Schizophrenia

Australia, China, Hong Kong, Taiwan, Malaysia, Korea, Republic of, New Zealand, Thailand, Philippines
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia

Schizophrenia
Janssen Pharmaceutical K.K.

Completed

An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia

Schizophrenia
Zogenix, Inc.

Completed

To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules

Healthy
University of Maryland, Baltimore

Withdrawn

Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study

Schizophrenia

United States
Janssen Scientific Affairs, LLC

Completed

A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder

Schizoaffective Disorder

United States, Ukraine, Bulgaria, India, Malaysia, Romania, South Africa, Philippines
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder

Mood Disorders | Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone

Schizophrenia | Schizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305.

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate

Schizophrenia
Bnai Zion Medical Center

Completed

Intravenous Fluids Versus Naso/Orogastric-tube Feeding in Hospitalized Infants With Bronchiolitis

Viral Bronchiolitis

Israel
University of California, San Diego
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

FRESH-TEEN: Families Responsibility Education Support Health for Teens (FRESH-TEEN)

Overweight and Obesity

United States
Janssen-Cilag Pty Ltd

Completed

An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia

Schizophrenia

3

Subscribe